Home LiteratureArticle Details
PMID: 978134 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.

The Journal of experimental medicine ·Vol. 144 ·No. 4 ·1976-10-01 ·Pages 1076-93

Medicus RG, Götze O, Müller-Eberhard HJ

Abstract

In this study the physiological role of properdin and the differential subunit composition of the solid phase enzymes of the pathway have been explored. Cell-bound C3 and C5 convertase differ in their C3b requirement. Apparently one molecule of C3b is sufficient to allow formation of C3 convertase (C3b,B), whereas two or more are required for generation of C5 convertase (C3bn,B). This conclusion was drawn from results indicating the critical role of the spacial distribution of C3b molecules on the cell surface in enzyme formation. While the C3/C5 convertase is fully capable of acting on C5 and thereby initiating the assembly of the cytolytic membrane attack complex, it is exceedingly labile and vulnerable to destruction by the C3b inactivator. It is the apparent role of properdin to confer a degree of stability upon the labile enzyme and to protect its C3 convertase function against enzymatic destruction. To achieve these effects, precursor properdin (pre-P) is recruited in a binding-activation reaction by the labile C3/C5 convertase. Multiple C3b molecules appear to be needed for the formation of properdin-activating principle. Three modes of regulation have been described, which involve spontaneous dissociation enzymatic degradation by C3b inactivator and disassembly by beta1H. The functional differences of pre-P and activated properdin (P) were delineated, pre-P displaying a weak affinity for C3b and P the capacity of strong interaction, P generating a soluble C3 convertase in serum and pre-P being unable to do so. Because of the profound differences between native pre-P and the laboratory product P, the question was raised as to whether soluble P represents an unphysiological form of the protein. On the basis of this and other studies, the conclusion was reached that in vitro properdin recruitment constitutes the terminal event of the properdin pathway, and that properdin augments the function of C3/C5 convertase without changing its substrate specificity.

MeSH Terms
Animals Cell Membrane/metabolism Complement C3/metabolism Complement C5/metabolism Complement System Proteins/metabolism Erythrocytes/metabolism Esterases/metabolism Humans In Vitro Techniques Properdin/metabolism Protein Precursors/isolation & purification,metabolism Sheep
Chemicals
Complement C3 Complement C5 Protein Precursors Properdin Complement System Proteins Esterases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Medicus R G
Götze O
Müller-Eberhard H J
References (22)
22 references, click to expand
  1. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  2. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    J Exp Med. 1967 Feb 1;125(2):359-80 PMID: 6019133
  3. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    J Exp Med. 1976 Oct 1;144(4):1062-75 PMID: 62010
  4. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    J Exp Med. 1975 Oct 1;142(4):856-63 PMID: 1185108
  5. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    J Immunol. 1974 Jan;112(1):56-62 PMID: 4130153
  6. C3 proactivator convertase and its mode of action.
    J Exp Med. 1972 Apr 1;135(4):1003-8 PMID: 4111773
  7. A method of trace iodination of proteins for immunologic studies.
    Int Arch Allergy Appl Immunol. 1966;29(2):185-9 PMID: 4160044
  8. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.
    J Exp Med. 1973 Dec 1;138(6):1305-13 PMID: 4202731
  9. A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.
    J Exp Med. 1974 May 1;139(5):1249-61 PMID: 4207623
  10. Multiple sedimenting species of properdin in human serum and interaction of purified properdin with the third component of complement.
    J Exp Med. 1976 Feb 1;143(2):241-57 PMID: 2647
  11. Studies on the sub-unit structure of human properdin.
    Immunochemistry. 1974 Jul;11(7):361-8 PMID: 4477550
  12. The role of properdin in the alternate pathway of complement activation.
    J Exp Med. 1974 Jan 1;139(1):44-57 PMID: 4808709
  13. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    J Immunol. 1973 Nov;111(5):1389-400 PMID: 4795621
  14. Isolation and characterization of the proenzyme form of the C1r subunit of the first complement component.
    J Immunol. 1974 May;112(5):1667-73 PMID: 4818459
  15. Molecular analysis of the membrane attack mechanism of complement.
    J Exp Med. 1972 Mar 1;135(3):549-66 PMID: 5058233
  16. A molecular concept of immune cytolysis.
    Arch Pathol. 1966 Sep;82(3):205-17 PMID: 5329367
  17. Inhibition of complement-derived enzymes.
    Ann N Y Acad Sci. 1975 Jun 13;256:441-50 PMID: 808993
  18. Properdin: initiation of alternative complement pathway.
    Proc Natl Acad Sci U S A. 1975 Aug;72(8):3220-4 PMID: 1059108
  19. Purification of the sixth and seventh component of human complement without loss of hemolytic activity.
    J Immunol. 1976 Feb;116(2):263-9 PMID: 1249415
  20. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
    J Exp Med. 1975 Sep 1;142(3):760-72 PMID: 1165475
  21. The second component of human complement (C2): quantitative molecular analysis of its reactions in immune hemolysis.
    Immunochemistry. 1970 Apr;7(4):341-56 PMID: 5464477
  22. Chromatographic resolution of the first component of human complement into three activities.
    J Exp Med. 1963 Jun 1;117:983-1008 PMID: 13929797
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1976-10-01
Pages
1076-93
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2190426
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]